Breaking News

Ei Expands Capabilities Through KeraNetics Partnership

To invest $13.2 million in expansion, will manufacture advanced biomaterial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ei, A Pharmaceutical SolutionWorks has entered a new partnership with KeraNetics, a biomaterials company focused on creating keratin-based products for use in regenerative medicine and trauma care. Additionally, Ei began a $13.2 million expansion at its recently completed 147,000-sq.-ft. facility in Kannapolis, NC, broadening its manufacturing capabilities. Ei is providing product formulation and development to commercialize KeraNetics’ patented product lines and will manufacture an advanced bio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters